AllGLP1
For Journalists
InsightsBlogTake Quiz
Take Quiz
AllGLP1

Your independent guide to GLP-1 weight loss medications. Compare prices, read reviews, and find the best provider for you.

Trust & Transparency

  • Our Methodology
  • Affiliate Disclosure
  • Correction Log

Popular Searches

  • Zepbound vs Wegovy
  • GLP-1 Side Effects
  • Henry Meds Review
  • Hims Review
  • Direct Meds Review
  • Ivim Health Review

Resources

  • GLP-1 Research
  • Nutrition Guide
  • Shortage Tracker
  • Reddit User Research
  • Free Widget
  • Newsletter
  • Blog

Company

  • About AllGLP1
  • Contact
  • Privacy Policy
  • Terms of Service
  • Disclaimer
The Weekly Dose

The newsletter for your GLP-1 journey

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Consult with a healthcare provider before starting any medication. AllGLP1 is not a healthcare provider and does not prescribe medications.

Affiliate Disclosure: AllGLP1 may earn commission from provider referrals. This does not affect our recommendations or pricing information. We only recommend providers we believe offer value to our users.

© 2026 AllGLP1. All rights reserved.

PrivacyTermsSitemap
First Daily GLP-1 Pill for Weight Loss Gets FDA Approval
Back to Blog
Daily Roundup
AI-assisted content

First Daily GLP-1 Pill for Weight Loss Gets FDA Approval

April 2, 20263 MIN TO READ

Eli Lilly's new pill version just got approved, and it's way more convenient than the shots we're used to.

Finally, a GLP-1 Pill You Can Actually Live With

The FDA just approved Foundayo (orforglipron) from Eli Lilly, and honestly, this feels like what we've been waiting for. Unlike other GLP-1 pills that come with a laundry list of timing requirements, you can take this one whenever works for you – no need to worry about food, water, or that annoying empty stomach rule.

In the main trial called ATTAIN-1, people taking the highest dose lost an average of 27.3 pounds over the study period. That's about 12.4% of their starting weight, compared to just 2.2 pounds for folks on placebo. Those numbers put it right in the ballpark with Zepbound and other injectable options we already know work.

The Price Tag Might Actually Be Reasonable

Here's where things get interesting – Lilly says Foundayo will start at $25 per month if you have commercial insurance coverage. For those paying out of pocket, it's $149 monthly through LillyDirect with free home delivery. That's significantly less than what most people are shelling out for Mounjaro or other brand-name GLP-1s right now.

The convenience factor here is huge. No more setting alarms for 30 minutes before breakfast or chugging water on an empty stomach. You can literally take it with your morning coffee, afternoon snack, or late-night TV watching – whatever fits your actual life.

What We Don't Know Yet

Lilly's press release was pretty light on side effects, which makes me wonder if they're similar to what we see with other GLP-1s. Most people still deal with nausea, especially when starting out, but we'll need more real-world experience to know how this pill compares.

The company says it'll be available through LillyDirect, but we don't have a specific launch date beyond "soon." If you're currently struggling with injection schedules or can't get consistent coverage for other options, this might be worth discussing with your doctor.

Bottom Line

Foundayo could be a solid option if you want GLP-1 benefits without injection anxiety or strict timing rules. The pricing looks competitive, especially with insurance. Just remember that even pills can have side effects, and weight loss still requires the same lifestyle changes that make any of these medications work long-term.

Secondary illustration
Back to all posts